Could Nate Diaz seriously be plotting a UFC comeback? He's at least talking like he is. Diaz (21-13 MMA, 16-11 UFC) amicably parted ways with the UFC after submitting Tony Ferguson in September 2022.

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...